PROSPECTIVE CLINICAL STUDY ON THE VALUE OF NUCLEAR MATRIX PROTEIN (NMP22) AS A URINARY TUMOR MARKER IN THE DIAGNOSIS AND FOLLOW UP OF PATIENTS WITH BLADDER CANCER
Amr Mohamed Abd-Eltwab Yehia;
Abstract
BACKGROUND: Carcinoma of the bladder is responsible for a large percentage of mortality due to cancer worldwide. In Egypt, it is the commonest malignancy affecting men. Early diagnosis of bladder cancer could detect small tumor at early stage. Several ur
Other data
| Title | PROSPECTIVE CLINICAL STUDY ON THE VALUE OF NUCLEAR MATRIX PROTEIN (NMP22) AS A URINARY TUMOR MARKER IN THE DIAGNOSIS AND FOLLOW UP OF PATIENTS WITH BLADDER CANCER | Authors | Amr Mohamed Abd-Eltwab Yehia | Keywords | PROSPECTIVE CLINICAL STUDY ON THE VALUE OF NUCLEAR MATRIX PROTEIN (NMP22) AS A URINARY TUMOR MARKER IN THE DIAGNOSIS AND FOLLOW UP OF PATIENTS WITH BLADDER CANCER | Issue Date | 2007 | Description | BACKGROUND: Carcinoma of the bladder is responsible for a large percentage of mortality due to cancer worldwide. In Egypt, it is the commonest malignancy affecting men. Early diagnosis of bladder cancer could detect small tumor at early stage. Several ur |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 73739r32.pdf | 557.33 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.